These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39060886)

  • 1. Background parenchymal enhancement on contrast-enhanced mammography: associations with breast density and patient's characteristics.
    Magni V; Cozzi A; Muscogiuri G; Benedek A; Rossini G; Fanizza M; Di Giulio G; Sardanelli F
    Radiol Med; 2024 Sep; 129(9):1303-1312. PubMed ID: 39060886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
    AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
    AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
    Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
    Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep-learning model for background parenchymal enhancement classification in contrast-enhanced mammography.
    Ripaud E; Jailin C; Quintana GI; Milioni de Carvalho P; Sanchez de la Rosa R; Vancamberg L
    Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38657641
    [No Abstract]   [Full Text] [Related]  

  • 6. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
    Savaridas SL; Taylor DB; Gunawardana D; Phillips M
    Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Background Parenchymal Enhancement at Contrast-Enhanced Spectral Mammography (CESM) as a Breast Cancer Risk Factor.
    Sorin V; Yagil Y; Shalmon A; Gotlieb M; Faermann R; Halshtok-Neiman O; Sklair-Levy M
    Acad Radiol; 2020 Sep; 27(9):1234-1240. PubMed ID: 31812577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI.
    Yuen S; Monzawa S; Gose A; Yanai S; Yata Y; Matsumoto H; Ichinose Y; Tashiro T; Yamagami K
    Breast Cancer; 2022 Jul; 29(4):677-687. PubMed ID: 35220511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of Screening Contrast-enhanced Mammography for Women with Extremely Dense Breasts at Increased Risk of Breast Cancer.
    Nissan N; Comstock CE; Sevilimedu V; Gluskin J; Mango VL; Hughes M; Ochoa-Albiztegui RE; Sung JS; Jochelson MS
    Radiology; 2024 Oct; 313(1):e232580. PubMed ID: 39352285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.
    Ko KH; Jung HK; Kim I
    Medicine (Baltimore); 2017 Aug; 96(33):e7850. PubMed ID: 28816987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI.
    Ma Y; Liu A; Zhang Y; Zhu Y; Wang Y; Zhao M; Liang Z; Qu Z; Yin L; Lu H; Ye Z
    Eur Radiol; 2022 Aug; 32(8):5773-5782. PubMed ID: 35320411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
    Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
    J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.
    Yu L; Wang Y; Xing D; Gong P; Chen Q; Lv Y
    Medicine (Baltimore); 2020 Dec; 99(52):e23857. PubMed ID: 33350778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative assessments of density and background parenchymal enhancement on contrast-enhanced spectral mammography associated with breast cancer risk in high-risk women.
    Xu C; Jiang M; Lin F; Zhang K; Xie H; Lv W; Ji H; Mao N
    Br J Radiol; 2023 Aug; 96(1148):20220051. PubMed ID: 37227804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging.
    Yoon HJ; Kim Y; Lee JE; Kim BS
    Eur Radiol; 2015 Jan; 25(1):32-40. PubMed ID: 25216768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
    Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
    Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.
    Sung JS; Corben AD; Brooks JD; Edelweiss M; Keating DM; Lin C; Morris EA; Patel P; Robson M; Woods M; Bernstein JL; Pike MC
    Breast Cancer Res Treat; 2018 Nov; 172(2):487-496. PubMed ID: 30140962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Background Parenchymal Enhancement in Contrast-enhanced Spectral Mammography: A Retrospective Analysis and a Pictorial Review of Clinical Cases.
    Meucci R; Pistolese CA; Perretta T; Vanni G; Beninati E; DI Tosto F; Serio ML; Caliandro A; Materazzo M; Pellicciaro M; Buonomo OC
    In Vivo; 2022; 36(2):853-858. PubMed ID: 35241542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Diao P; Nielsen MB; Uldall WY; Vejborg I
    BMC Cancer; 2015 Apr; 15():274. PubMed ID: 25884160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing.
    Zhao S; Zhang X; Zhong H; Qin Y; Li Y; Song B; Huang J; Yu J
    Sci Rep; 2020 May; 10(1):8608. PubMed ID: 32451404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.